Brolucizumab
Brolucizumab
Immunoglobulin scFv, anti-[Homo sapiens VEGFA (vascular endothelial growth factor A, VEGF-A, VEGF)], humanized monoclonal antibody single chain; scFv (1-252) methionyl (1)-humanized V-KAPPA Homo sapiens IGKV1-5*01 (87.60%)-IGKJ2*01E125>T (108), I1
Stoffgruppe
Ophthalmikum (antineovaskuläres Mittel, VEGF-Inhibitor)